1. Home
  2. PHGE vs MRM Comparison

PHGE vs MRM Comparison

Compare PHGE & MRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHGE
  • MRM
  • Stock Information
  • Founded
  • PHGE 2015
  • MRM 2000
  • Country
  • PHGE Israel
  • MRM Japan
  • Employees
  • PHGE N/A
  • MRM N/A
  • Industry
  • PHGE Biotechnology: Pharmaceutical Preparations
  • MRM Other Consumer Services
  • Sector
  • PHGE Health Care
  • MRM Consumer Discretionary
  • Exchange
  • PHGE Nasdaq
  • MRM Nasdaq
  • Market Cap
  • PHGE 13.3M
  • MRM 12.2M
  • IPO Year
  • PHGE N/A
  • MRM 2020
  • Fundamental
  • Price
  • PHGE $0.59
  • MRM $0.49
  • Analyst Decision
  • PHGE Strong Buy
  • MRM
  • Analyst Count
  • PHGE 2
  • MRM 0
  • Target Price
  • PHGE $23.00
  • MRM N/A
  • AVG Volume (30 Days)
  • PHGE 184.4K
  • MRM 3.8M
  • Earning Date
  • PHGE 05-19-2025
  • MRM 01-01-0001
  • Dividend Yield
  • PHGE N/A
  • MRM N/A
  • EPS Growth
  • PHGE N/A
  • MRM N/A
  • EPS
  • PHGE N/A
  • MRM N/A
  • Revenue
  • PHGE N/A
  • MRM $44,462,062.00
  • Revenue This Year
  • PHGE N/A
  • MRM N/A
  • Revenue Next Year
  • PHGE N/A
  • MRM N/A
  • P/E Ratio
  • PHGE N/A
  • MRM N/A
  • Revenue Growth
  • PHGE N/A
  • MRM 2.80
  • 52 Week Low
  • PHGE $0.48
  • MRM $0.34
  • 52 Week High
  • PHGE $4.99
  • MRM $8.39
  • Technical
  • Relative Strength Index (RSI)
  • PHGE 46.36
  • MRM 46.78
  • Support Level
  • PHGE $0.48
  • MRM $0.34
  • Resistance Level
  • PHGE $0.70
  • MRM $0.89
  • Average True Range (ATR)
  • PHGE 0.06
  • MRM 0.08
  • MACD
  • PHGE 0.01
  • MRM 0.02
  • Stochastic Oscillator
  • PHGE 50.54
  • MRM 31.44

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.

About MRM MEDIROM Healthcare Technologies Inc.

MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.

Share on Social Networks: